SCHEMBL8287520

SCHEMBL8287520

CC(C)S(=O)(=O)N1CCN(c2cc3c(cn2)c(=O)cc(Nc2ccccc2)n3-c2ccccc2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.39
JAK2 O60674 1/20 0.38
BRD4 O60885 1/20 0.38
NAMPT P43490 1/20 0.36
ALDH1A1 P00352 2/20 0.35
GSK3B P49841 2/20 0.35
LMNA P02545 1/20 0.34
GBA1 P04062 1/20 0.34
HTR1A P08908 1/20 0.34
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
GPR119 Q8TDV5 1/20 0.33
RORC P51449 2/20 0.33
KRAS P01116 1/20 0.33
SOS1 Q07889 1/20 0.33
TNF P01375 1/20 0.32
LITAF Q99732 1/20 0.32
LCK P06239 1/20 0.32
SRC P12931 1/20 0.32
CYP17A1 P05093 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8362922 0.91 ALDH1A1 (0.42) PDE11AJAK2BRD4ALDH1A1LMNA
SCHEMBL8285282 0.89 ALDH1A1 (0.42) PDE11AALDH1A1GSK3BLMNAMEN1
SCHEMBL8287497 0.86 PDE11A (0.46) PDE11AALDH1A1GSK3BLMNALCK
SCHEMBL8361778 0.86 CDK4 (0.43) PDE11AALDH1A1GSK3BLCKSRC
SCHEMBL8287223 0.85 PDE11A (0.39) PDE11AJAK2BRD4ALDH1A1LMNA
SCHEMBL8286467 0.84 PDE11A (0.44) PDE11AALDH1A1GSK3BLMNACDK4
SCHEMBL8287210 0.83 PDE11A (0.43) PDE11AALDH1A1GSK3BLMNATSHR
SCHEMBL8287227 0.83 PDE11A (0.37) PDE11ANAMPTALDH1A1GSK3BLMNA
SCHEMBL8287220 0.82 CKS1B (0.41) PDE11ACDK4CCND1CCND2CCND3
SCHEMBL8287946 0.82 CDK4 (0.43) PDE11AALDH1A1CDK4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed